The ongoing pandemic of coronavirus (CoV) disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …

The ongoing pandemic of Coronavirus disease 2019 (COVID-19) continues to exert a
significant burden on health care systems worldwide. With limited treatments available …

The ongoing COVID-19 pandemic has resulted in global effects on human health, economic
stability, and social norms. The emergence of viral variants raises concerns about the …

Background To investigate a vaccine technology with potential to protect against
coronavirus disease 2019 (COVID-19) and reduce transmission of severe acute respiratory …

Background Vaccines against COVID-19 are needed to overcome challenges associated
with mitigating the global pandemic. We report the safety and immunogenicity of V590, a live …

The continued progression of the COVID-19 pandemic can partly be attributed to the ability
of SARS-CoV-2 to mutate and introduce new viral variants. Some of these variants with the …

The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains
an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV) …

Current coronavirus disease-19 (COVID-19) vaccines are administered by the intramuscular
route, but this vaccine administration failed to prevent severe acute respiratory syndrome …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as the prime
challenge facing public health safety since 2019. Correspondingly, coronavirus disease …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of
human infections, and an effective vaccine is critical to mitigate coronavirus-induced disease …